Putnam BioRevolution ETF Rating $28.98 +0.02 (+0.07%) Closing price 08/8/2025 04:10 PM EasternExtended Trading$28.97 -0.01 (-0.03%) As of 08/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.79Holdings in SYNB have an aggregate rating of Moderate Buy based on 506 analyst ratings issued in the past year covering 32 companies (92.9% of the portfolio).SYNB Aggregate Price Target$28.98High Prediction$28.98Average Prediction$28.98Low Prediction$28.98Holdings in SYNB have an aggregate price target of $28.98 and a range of $28.98 to $28.98 covering 32 companies (92.9% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.92%TMOThermo Fisher Scientific$461.34+1.5%4.9918 of 5 stars2.71$593.00 28.5%21Positive NewsInsider Trade6.38%CTVACorteva$70.87-0.3%4.7399 of 5 stars2.86$79.50 12.2%14Trending NewsEarnings ReportAnalyst Forecast6.09%NVZMYNovozymes A/S$65.51-1.3%2.7127 of 5 stars3.0035.19%ABBVAbbVie$198.10-0.4%4.6886 of 5 stars2.93$214.43 8.2%27Trending NewsAnalyst UpgradeInsider Trade4.80%BIOBio-Rad Laboratories$264.45-0.3%4.8815 of 5 stars2.75$333.50 26.1%44.75%NVDANVIDIA$182.67+1.1%4.6603 of 5 stars2.93$183.75 0.6%42Trending NewsInsider Trade4.46%AZNAstraZeneca$73.56-1.4%3.4654 of 5 stars2.83$89.00 21.0%6Positive NewsAnalyst Revision4.29%ASNDAscendis Pharma A/S$191.49+0.6%3.4275 of 5 stars3.00$239.80 25.2%15Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume4.03%ZTSZoetis$147.34-0.6%4.7556 of 5 stars2.56$204.63 38.9%9Trending NewsEarnings ReportAnalyst Revision3.82%LLYEli Lilly and Company$625.15-2.5%4.9993 of 5 stars2.67$984.41 57.5%21Trending NewsEarnings ReportAnalyst DowngradeInsider TradeGap UpHigh Trading Volume3.62%CDNSCadence Design Systems$352.06-0.6%4.4563 of 5 stars2.73$364.33 3.5%15Positive NewsInsider Trade3.31%DDDuPont de Nemours$70.44-0.6%4.7213 of 5 stars2.75$88.25 25.3%12Positive NewsEarnings ReportAnalyst Forecast3.18%DHRDanaher$200.70+1.1%4.8471 of 5 stars2.85$247.61 23.4%20News CoveragePositive News2.92%REGNRegeneron Pharmaceuticals$563.00+0.6%4.9146 of 5 stars2.75$832.73 47.9%24Positive NewsEarnings ReportDividend AnnouncementAnalyst Revision2.84%ICLRIcon$158.44+0.4%4.5438 of 5 stars2.81$219.54 38.6%16Positive News2.79%DARDarling Ingredients$30.63-0.2%4.476 of 5 stars2.78$45.86 49.7%9Positive News2.57%ONONON$45.61+1.0%4.0013 of 5 stars2.95$64.00 40.3%22Positive NewsUpcoming EarningsAnalyst Forecast2.36%NGVTIngevity$51.34+1.6%1.4332 of 5 stars2.50$55.00 7.1%2News CoverageEarnings ReportAnalyst Forecast2.33%AVTRAvantor$11.51+1.1%4.7675 of 5 stars2.47$15.50 34.7%15Earnings ReportAnalyst Revision2.12%TECHBio-Techne$50.42+0.5%4.9161 of 5 stars2.62$69.42 37.7%13News CoverageEarnings ReportDividend AnnouncementAnalyst Forecast2.06%BNBrookfield$64.69-0.3%4.5608 of 5 stars3.11$74.56 15.3%9Trending NewsEarnings ReportAnalyst ForecastStock SplitAnalyst Revision1.66%PPGPPG Industries$106.94+0.8%4.6302 of 5 stars2.53$129.82 21.4%15Positive NewsAnalyst Revision1.66%ARGXargenex$661.83-1.6%4.1161 of 5 stars3.10$746.81 12.8%20News CoveragePositive News1.54%VRTXVertex Pharmaceuticals$366.54-2.4%4.9273 of 5 stars2.56$497.10 35.6%27Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision1.47%BMRNBioMarin Pharmaceutical$57.33-3.6%4.9941 of 5 stars2.75$93.17 62.5%24Trending NewsAnalyst ForecastAnalyst Revision1.42%ALNYAlnylam Pharmaceuticals$438.93+0.9%3.9107 of 5 stars2.85$403.92 -8.0%27Analyst ForecastAnalyst Revision1.10%BIIBBiogen$130.67+2.3%4.9132 of 5 stars2.34$185.63 42.1%32Analyst Revision1.05%BGBunge Global$83.04+0.4%4.1159 of 5 stars2.40$81.60 -1.7%5Positive News0.87%SANBanco Santander$9.31+2.5%2.9705 of 5 stars2.8050.57%LEGNLegend Biotech$37.00-1.1%3.8323 of 5 stars3.00$73.33 98.2%11News CoverageUpcoming EarningsAnalyst Revision0.41%ABSIAbsci$2.84-2.7%3.0218 of 5 stars3.00$8.28 191.5%5Upcoming Earnings0.35%CRSPCRISPR Therapeutics$55.00-1.7%3.688 of 5 stars2.50$71.60 30.2%16Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision This page (NYSEARCA:SYNB) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
